ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Early Rheumatoid Arthritis"

  • Abstract Number: 2015 • 2017 ACR/ARHP Annual Meeting

    Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and  Early Spondyloarthritis. Α Monocentric Preliminary Study

    Alberto Batticciotto1, Giada Prato2, Marco Antivalle2, Maria Chiara Ditto1, Maria Chiara Gerardi2, Rossella Talotta2, Federica Rigamonti2, Fabiola Atzeni1 and Piercarlo Sarzi-Puttini2, 1Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy

    Background/Purpose: A number of studies have demonstrated that musculoskeletal ultrasonography (MSUS) is more sensitive in diagnosing arthritis than clinical examination although, as underlined in a…
  • Abstract Number: 955 • 2017 ACR/ARHP Annual Meeting

    In Vitro Effects of CR6086, a Potent ProstaglandinE2 Subtype 4 Receptor Antagonist, on Bone Erosive Pathways

    Tiziana Piepoli1, Mario Montagna1, Daniele Maggioni1, Silvia Zerbi1, Laura Mennuni1, Marco Lanza1, Gianfranco Caselli1 and Lucio C. Rovati2, 1Rottapharm Biotech, Monza, Italy, 2Clinical Research Department, Rottapharm Biotech, Monza, Italy

    Background/Purpose: CR6086 is a selective EP4 receptor antagonist immunomodulator in clinical development for rheumatoid arthritis (RA). In animal models of RA, it demonstrated a superior…
  • Abstract Number: 2042 • 2017 ACR/ARHP Annual Meeting

    Referral Criteria to an Early Arthritis Clinic: Poor Agreement between Referring Physicians and Rheumatologists

    Filipa Farinha1,2, Gisela Eugénio2, Mary Marques2, Francisco Freitas3, José António P. da Silva2,4 and Cátia Duarte2,4, 1Rheumatology, Centro Hospitalar do Baixo Vouga, E.P.E., Aveiro, Portugal, 2Rheumatology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 3Centre for Social Studies, Universidade de Coimbra, Coimbra, Portugal, 4Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal

    Background/Purpose: Prompt identification and referral of patients with suspected inflammatory arthritis to a rheumatology clinic are crucial for early diagnosis and treatment. In the referral…
  • Abstract Number: 1250 • 2017 ACR/ARHP Annual Meeting

    Outcomes in Real-World Patients with Early Aggressive Rheumatoid Arthritis

    Keith Knapp1,2, Eric Mueller1,2 and Gary Craig1,2, 1Arthritis Northwest PLLC., Spokane, WA, 2Discus Analytics LLC., Spokane, WA

    Background/Purpose: The window of opportunity to address early rheumatoid arthritis (RA) in patients (pts) is well documented. However early aggressive (agr) RA needs further study…
  • Abstract Number: 2375 • 2017 ACR/ARHP Annual Meeting

    Does the Body Mass Index Have Any Influence in the Characteristics of Early Arthritis Patients?

    Pablo Moreno Fresneda1, Lola Martínez-Quintanilla Jiménez1, Ana M. Ortiz Garcia2, Eva Tomero3, Rosario García-Vicuña4 and Isidoro Gonzalez-Alvaro2, 1Rheumatology, Rheumatology Division, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain, 2Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 3Hospital La Princesa. Madrid., Madrid, Spain, 4Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain

    Background/Purpose: Obesity has been proposed as a risk factor to develop rheumatoid arthritis (RA) and it has been associated with a worse response to several…
  • Abstract Number: 1253 • 2017 ACR/ARHP Annual Meeting

    Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

    Samina A. Turk1,2, Linda A. Rasch3, Willem F. Lems4,5, Lilian van Tuyl3, Dirkjan van Schaardenburg4,6 and Marieke M. Ter Wee5,7, 1Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 5Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 6Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 7Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients increasingly reach a state of absence of disease activity, or remission. However, the proportion of patients classified as in remission…
  • Abstract Number: 2390 • 2017 ACR/ARHP Annual Meeting

    Trends and Predictors of Guideline Adherence for Glucocorticoid-Induced Osteoporosis Prevention in an Early Rheumatoid Arthritis Cohort

    Stephanie Gottheil1, Orit Schieir2, Carter Thorne3, Carol A Hitchon4, Diane Tin5, Edward C. Keystone6, Gilles Boire7, Boulos Haraoui8, Susan J. Bartlett9, Vivian P. Bykerk10 and Janet E. Pope11, 1University of Western Ontario, LONDON, ON, Canada, 2McGill University, Montreal, ON, Canada, 3University of Toronto, Newmarket, ON, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 6Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, 7Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 8Institute de Rheumatologie, Montreal, QC, Canada, 9Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 102-005, Mt Sinai Hospital, Toronto, ON, Canada, 11Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada

    Background/Purpose: RA patients are at a high risk of osteoporosis and fracture, in part due to frequent glucocorticoid use. Despite recommendations from ACR guidelines on…
  • Abstract Number: 1356 • 2017 ACR/ARHP Annual Meeting

    Is ACPA-Positive RA Still a More Severe Disease Than ACPA-Negative RA? a Longitudinal Cohort Study in RA-Patients Treated from 2000 Onwards

    Aleid C. Boer1, Annelies Boonen2 and Annette H.M. van der Helm-van Mil3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+, Maastricht, The Netherlands, Maastricht, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Anti-citrullinated-protein antibodies (ACPA)-positive rheumatoid arthritis (RA) is considered as more severe than ACPA-negative RA, because of its association with joint destruction. Clinically relevant joint…
  • Abstract Number: 2391 • 2017 ACR/ARHP Annual Meeting

    Incidence of Infections in Early Arthritis

    Meriem Kerbachi1, Louis Bessette2, Cristiano S. Moura3, Sasha Bernatsky4, Orit Schieir5, Susan J. Bartlett6, Carol A Hitchon7, Janet E. Pope8, Gilles Boire9, Boulos Haraoui10, Edward C. Keystone11, Diane Tin12, Carter Thorne13 and Vivian P. Bykerk14, 1McGill University, Montreal, QC, Canada, 2Centre d'ostéoporose et de rhumatologie de Québec (CORQ), Québec, QC, Canada, 31Division of Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 4Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 5McGill University, Montreal, ON, Canada, 6Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 9Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 10Institut de Rhumatologie de Montréal, Montreal, QC, Canada, 11Mt. Sinai Hospital, University of Toronto, Toronto, ON, Canada, 12The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 13University of Toronto, Newmarket, ON, Canada, 142-005, Mt Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: Few studies have focused on analyzing infection risk in recent-onset rheumatoid arthritis (RA).The main objective of this study was to estimate the incidence of…
  • Abstract Number: 1369 • 2017 ACR/ARHP Annual Meeting

    Interferon Gamma Signature Genes and CXCL10 As New Biomarkers in Early Stage of Rheumatoid Arthritis

    Kijun Lee1, Jennifer Lee2, Hong-Ki Min1, Hae-Rim Kim3, Sang-Heon Lee4, Sung-Hwan Park5, Ji Hyeon Ju6 and Hoyoun Kim1, 1The Catholic University of Korea, Seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 3Konkuk University Medical Center, Seoul, Korea, Republic of (South), 4Konkuk University School of Medicine, Seoul, Korea, Republic of (South), 5Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 6Division of Rheumatology, Department of Internal Medicine,, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

    Background/Purpose: The purpose of this study is to explore new biomarkers for early diagnosis of rheumatoid arthritis (RA). For better discrimination power, we especially investigated…
  • Abstract Number: 2426 • 2017 ACR/ARHP Annual Meeting

    Altered Frequencies of Circulating Follicullar T Helper Cell Counterparts and Their Subsets but Not of Peripheral Helper T Cells, Are Associated with Increased Circulating Plasmablasts in Seropositive Early RA Patients

    Paula Fortea-Gordo1, Lorena Valdeolivas-De Opazo1, Laura Nuño2, Alejandro Villalba1, Paloma Sanchez-Mateos3, Amaya Puig-Kröger4, Alejandro Balsa1 and Maria Eugenia Miranda-Carus1, 1Rheumatology, Hospital La Paz-IdiPAZ, Madrid, Spain, 2Rheumatology, La Paz University Hospital, Madrid, Spain, 3Immunology, Hospital Gregorio Marañon, Madrid, Spain, 4Immuno-oncology, Hospital Gregorio Marañon, Madrid, Spain

    Background/Purpose: Follicular T helper (Tfh) cells are typically located in lymphoid organs where they promote B cell differentiation and function. Circulating CD4 T cells expressing…
  • Abstract Number: 1386 • 2017 ACR/ARHP Annual Meeting

    Tenosynovitis in the Forefoot at Disease Presentation Is Specific for RA: Results from a Cross-Sectional MRI Study in Early Arthritis

    Yousra J. Dakkak1, Debbie M. Boeters2, Annette H.M. van der Helm-van Mil2 and M. Reijnierse3, 1Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The foot is a preferential location for rheumatoid arthritis (RA)-manifestation, but physical examination of the metatarsophalangeal (MTP) joints is difficult. Magnetic Resonance Imaging (MRI)…
  • Abstract Number: 2456 • 2017 ACR/ARHP Annual Meeting

    Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

    Arthur Kavanaugh1, Ronald F van Vollenhoven2, Prashanth Sunkureddi3, Ying Zhang4, Jessica L. Suboticki5 and Josef S. Smolen6, 1Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, CA, 2Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, Netherlands, 3University of Texas Medical Branch, Galveston, TX, 4AbbVie Inc., North Chicago, IL, 5AbbVie Inc., Mettawa, IL, 6Division of Rheumatology, Department of Medicine, Medical University of Vienna, and Hietzing Hospital, Vienna, Austria

    Background/Purpose : Some rheumatoid arthritis (RA) patients (pts) may experience flares in their disease even after reaching stable low disease activity (sLDA), but the consequences…
  • Abstract Number: 1393 • 2017 ACR/ARHP Annual Meeting

    Patient Characteristics, Treatment Strategy or Investigator Effect: An Analysis of Factors Driving Variation in Outcomes in Early Rheumatoid Arthritis

    Cheryl Barnabe1, Orit Schieir2, Glen Hazlewood1, Susan J. Bartlett3, Carol A Hitchon4, Janet E. Pope5, Gilles Boire6, Edward C. Keystone7, Diane Tin8, B Haraoui9, Vivian P. Bykerk10 and Carter Thorne11, 1Division of Rheumatology, University of Calgary, Calgary, AB, Canada, 2Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 3Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 6Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 7University of Toronto, Toronto, ON, Canada, 8The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 9Institut de Recherche en Rhumatologie de Montréal (IRRM), Montreal, QC, Canada, 102-005, Mt Sinai Hospital, Toronto, ON, Canada, 11University of Toronto, Newmarket, ON, Canada

    Background/Purpose: Outcomes in ERA are largely thought to reflect individual prognostic factors and treatment strategy employed. We hypothesize that an additional factor may be the…
  • Abstract Number: 2939 • 2017 ACR/ARHP Annual Meeting

    Clinical Correlate of Synovial Proliferation in Early Rheumatoid Arthritis

    Fan XIAO1, JIANG YUE2, Queenie Mak3, Lai-Shan Tam4 and James F Griffith5, 1Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, HONG KONG, Hong Kong, 3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 4Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 5Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, HONGKONG, Hong Kong

     Clinical Correlate of Synovial Proliferation in Early Rheumatoid Arthritis  Background/Purpose: To determine whether semi-quantitative, quantitative assessment of synovitis severity or synovial perfusion data correlates best…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology